Multicentre, double-dummy, randomized, double-blind comparison between mitiglinide and nateglinide in the patients with type 2 diabetes

Trial Profile

Multicentre, double-dummy, randomized, double-blind comparison between mitiglinide and nateglinide in the patients with type 2 diabetes

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Mitiglinide (Primary) ; Nateglinide
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Kissei Pharmaceutical
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Aug 2009 Non-inferioirty results published in Journal of International Medical Research May-Jun 2009.
    • 20 Oct 2008 Actual patient number (291) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top